CDMO Bend Bioscience announced the addition of a commercial-scale spray dryer and a Gerteis dry granulation system at its facility in Gainesville, Georgia.
The addition of the equipment will expand the 120,000-square-foot facility’s capabilities to provide technologically advanced absorption and bioavailability-enhanced products, and comprehensive clinical and commercial scale oral dose forms.
Featuring a state-of-the-art GEA PSD-4, the new spray drying suite will include adjacent secondary vacuum drying systems, multiple tank sizes to accommodate flexible campaigns and batch sizes, a dual-stage condenser capable of handling a wide range of process solvents, and the ability to process highly potent APIs.
The Gainesville facility specializes in oral solid dosage forms, and is a center of excellence for commercial manufacturing, modified release and multiparticulates. It is equipped to handle DEA schedule (I-V) and potent compounds, and has its own analytical, late-phase tech transfer teams, and provides specialist packaging capabilities.
The new equipment is being shipped to the Gainesville facility this month and the installation process will begin immediately to align with potential customer timelines.